Evaluation of a type of therapy for the treatment of vaginal pain during intercourse.
- Conditions
- VulvodyniaC13.351.500.944.951
- Registration Number
- RBR-6z42q3
- Lead Sponsor
- Faculdade de Ciências Médicas - Universidade Estadual de Campinas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Women with vulvodynia symptons, for, at least 6 months
Women with positive test for vulvodynia
Women willing to participate and to accept and sign voluntarily, the consent term
Women who use intrauterine device
Pregnancy
Women who use pacemakers
Women who have some sort of metal implant in the region of the lumbar spine or hip
Women who have neoplasic diseases
Women with acute infectious process in the vulvar region
Chronic Immunosuppression
Deformity of the spine or pelvis
Genital ulcer
Women on medications that may cause mucositis (eg prolonged use of antibiotics, immunomodulators, chemotherapeutics)
Women with systemic or acute allergic framework (localized)
Women who are known to have chronic degenerative disease (eg Acquired immunodeficiency syndrome, renal transplant, lupus, tuberculosis)
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of pain during intercourse after tratamentro with interferential current evaluated by Visual Analog Scale, reported by the patient.;Improved sexual function score evaluated by the Female Sexual Function Index;<br> Improvement in pain on examination evaluated by visual analog scale
- Secondary Outcome Measures
Name Time Method Improved intravaginal basal tone, the maximum force of contraction of the vaginal muscles, and the resistance of the vaginal muscles, assessed before and after treatment using electromyographic analysis (uV) and pressure (mmHg) with the device Miotool.